A carregar...

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

PURPOSE: Despite recent improvements in therapeutic management of osteosarcoma, ongoing challenges in improving the response to chemotherapy warrants new strategies still needed to improve overall patient survival. Among new therapeutic approaches, zoledronic acid (ZOL) represents a promising adjuva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lamoureux, Francois, Baud'huin, Marc, Ory, Benjamin, Guiho, Romain, Zoubeidi, Amina, Gleave, Martin, Heymann, Dominique, Rédini, Françoise
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4202162/
https://ncbi.nlm.nih.gov/pubmed/25138053
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!